Wang Yixiao, Cao Yan, Ji Xiaohong, Li Ting, Xue Lu, Li Chanjuan, Jia Ruizhe, Ding Hongjuan
Women's Hospital of Nanjing Medical University, Nanjing Maternity and Child Health Care Hospital, Nanjing, China.
Front Cardiovasc Med. 2021 Dec 17;8:738378. doi: 10.3389/fcvm.2021.738378. eCollection 2021.
Preeclampsia (PE) is a serious risk to the health of pregnant women and fetuses during pregnancy, and there is no effective treatment for this condition. Although many reports have confirmed the therapeutic effects of peptides in diseases, the role of peptides in PE remains poorly understood. A differentially expressed peptide in PE (AEDPPE) is derived from heat-shock protein beta-1 (HSPB1), amino acids 100 to 109 (DVNHFAPDEL), which we identified in a previous study. We synthesized AEDPPE and investigated its effect on HTR-8/SVneo cell function using a Cell Counting Kit-8, flow cytometric assay, and Transwell and wound-healing assays. Quantitative reverse transcription-PCR and ELISA were used to determine cytokine expression. Pull-down assay, mass spectrometry, Western blot analysis, and immunofluorescence were used to explore the potential targets and signaling pathways regulated by AEDPPE. Finally, we assessed the effect of AEDPPE in the lipopolysaccharide (LPS)-induced PE-like rat model. AEDPPE significantly promoted the migration and invasion of HTR-8/SVneo cells, and it decreased the expression of interleukins 1 beta (IL-1β), interleukin 6 (IL-6), and interleukin 8 (IL-8). These functions performed by AEDPPE remained evident after injury to HTR-8/SVneo cells with tumor necrosis factor-alpha (TNF-α), and AEDPPE reversed the elevated sFlt-1/PlGF ratio induced by TNF-α. AEDPPE may exert these biological effects by binding to heat-shock protein 90β (HSP 90β) and, thus, affect the NF-κB signaling pathway. In an LPS-induced PE-like rat model, AEDPPE significantly improved PE symptoms and fetal rat outcomes. Our study showed that AEDPPE enhanced trophoblast migration and invasion and reduced inflammatory cytokine expression, and we hypothesized that these actions involved the NF-κB signaling pathway. The use of AEDPPE may thus develop into a novel modality in the treatment of PE.
子痫前期(PE)是孕期对孕妇和胎儿健康的严重威胁,且对此病症尚无有效治疗方法。尽管许多报道已证实肽在疾病中的治疗作用,但肽在PE中的作用仍知之甚少。我们在先前的研究中鉴定出一种源自热休克蛋白β-1(HSPB1)第100至109位氨基酸(DVNHFAPDEL)的子痫前期差异表达肽(AEDPPE)。我们合成了AEDPPE,并使用细胞计数试剂盒-8、流式细胞术检测、Transwell和伤口愈合试验研究了其对HTR-8/SVneo细胞功能的影响。采用定量逆转录-PCR和酶联免疫吸附测定法来确定细胞因子表达。通过下拉试验、质谱分析、蛋白质免疫印迹分析和免疫荧光法来探索AEDPPE调控的潜在靶点和信号通路。最后,我们评估了AEDPPE在脂多糖(LPS)诱导的子痫前期样大鼠模型中的作用。AEDPPE显著促进了HTR-8/SVneo细胞的迁移和侵袭,并降低了白细胞介素1β(IL-1β)、白细胞介素6(IL-6)和白细胞介素8(IL-8)的表达。在用肿瘤坏死因子-α(TNF-α)损伤HTR-8/SVneo细胞后,AEDPPE发挥的这些功能依然明显,并且AEDPPE逆转了TNF-α诱导的sFlt-1/PlGF比值升高。AEDPPE可能通过与热休克蛋白90β(HSP 90β)结合来发挥这些生物学效应,从而影响核因子κB信号通路。在LPS诱导的子痫前期样大鼠模型中,AEDPPE显著改善了子痫前期症状和胎鼠结局。我们的研究表明,AEDPPE增强了滋养层细胞的迁移和侵袭,并降低了炎性细胞因子表达,我们推测这些作用涉及核因子κB信号通路。因此,AEDPPE的应用可能会发展成为一种治疗子痫前期的新方法。